Integrated Target‐Based and Phenotypic Screening Approaches for the Identification of Anti‐Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated Target‐Based and Phenotypic Screening Approaches for the Identification of Anti‐Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA
Authors
Keywords
-
Journal
ChemMedChem
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-28
DOI
10.1002/cmdc.201900217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis
- (2018) Surendra Dawadi et al. ACS Medicinal Chemistry Letters
- A high content microscopy assay to determine drug activity against intracellular Mycobacterium tuberculosis
- (2017) Alyssa J. Manning et al. METHODS
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis
- (2016) Olivia Vergnolle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Breaking a pathogen's iron will: Inhibiting siderophore production as an antimicrobial strategy
- (2015) Audrey L. Lamb BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis
- (2015) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increasing the structural coverage of tuberculosis drug targets
- (2015) Loren Baugh et al. TUBERCULOSIS
- Iron acquisition strategies in mycobacteria
- (2015) Zhuo Fang et al. TUBERCULOSIS
- Iron-Regulated Protein HupB of Mycobacterium tuberculosis Positively Regulates Siderophore Biosynthesis and Is Essential for Growth in Macrophages
- (2014) S. D. Pandey et al. JOURNAL OF BACTERIOLOGY
- Pharmacokinetic andIn VivoEfficacy Studies of the Mycobactin Biosynthesis Inhibitor Salicyl-AMS in Mice
- (2013) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disruption of Mycobactin Biosynthesis Leads to Attenuation of Mycobacterium tuberculosis for Growth and Virulence
- (2013) P. Vineel Reddy et al. JOURNAL OF INFECTIOUS DISEASES
- Development of Mycobacterium tuberculosis Whole Cell Screening Hits as Potential Antituberculosis Agents
- (2013) Christopher B. Cooper JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship of Adenosine 5′-diphosphoribose at the Transient Receptor Potential Melastatin 2 (TRPM2) Channel: Rational Design of Antagonists
- (2013) Christelle Moreau et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
- (2012) Benjamin P. Duckworth et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Analyses of MbtB, MbtE, and MbtF Suggest Revisions to the Mycobactin Biosynthesis Pathway in Mycobacterium tuberculosis
- (2012) M. D. McMahon et al. JOURNAL OF BACTERIOLOGY
- Mutational and Phylogenetic Analyses of the Mycobacterial mbt Gene Cluster
- (2011) S. S. Chavadi et al. JOURNAL OF BACTERIOLOGY
- Open Babel: An open chemical toolbox
- (2011) Noel M O'Boyle et al. Journal of Cheminformatics
- Assessing compound binding to the Eg5 motor domain using a thermal shift assay
- (2009) Patricia A. McDonnell et al. ANALYTICAL BIOCHEMISTRY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More